| Bleeding events following concurrent use of warfarin and oseltamivir by Medicare beneficiaries. | Ann Pharmacother | 2013 Nov | 24285759 |
| Dabigatran etexilate for thromboembolic prophylaxis in non-valvular atrialfibrillation: the RE-LY study and substudies with commentary. | Expert Rev Cardiovasc Ther | 2013 Nov | 24147516 |
| New validated multiresidue analysis of six 4-hydroxy-coumarin anticoagulantrodenticides in hen eggs. | J Vet Diagn Invest | 2013 Nov | 24081927 |
| One-year adherence to warfarin treatment for venous thromboembolism in high-risk patients and its association with long-term risk of recurrent events. | J Manag Care Pharm | 2013 May | 23627575 |
| New alternative anticoagulants in atrial fibrillation: the move beyond warfarin. | Rev Recent Clin Trials | 2013 Jun | 23859143 |
| Supratherapeutic international normalized ratio due to reduced vitamin K intakesecondary to prolonged vomiting in a patient on warfarin. | Ann Pharmacother | 2013 Jun | 23719786 |
| Silicon and germanium nanoparticles with tailored surface chemistry as novelinorganic fiber brightening agents. | J Agric Food Chem | 2013 Jul 31 | 23822748 |
| Genotoxicity of Nicotiana tabacum leaves on Helix aspersa. | Genet Mol Biol | 2013 Jul | 23885210 |
| The changing face of oral anticoagulants. | Br Dent J | 2013 Jul | 23846055 |
| Review of recently approved alternatives to anticoagulation with warfarin foremergency clinicians. | J Emerg Med | 2013 Jul | 23375217 |